This inventor holds 3 USPTO granted patents. Top assignee: Munin Corporation. Active years: 2008-2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008-2010
Title: Cho-Yau Yeung: A Pioneer in Transcription Regulation and ECM Signaling
Introduction
Cho-Yau Yeung, an accomplished inventor based in Oak Park, IL, is recognized for his innovative contributions to the field of molecular biology and biotechnology. With a total of three patents to his name, Yeung has made significant strides in understanding the complexities of transcription regulation and extracellular matrix (ECM) signaling mechanisms.
Latest Patents
Yeung's latest patents reflect his expertise and forward-thinking approach. The first patent introduces the discovery of a novel transcription regulator known as the G+C-rich promoter binding protein (mGPBP). This invention elucidates the interaction patterns of mGPBP with other transcription factors, alongside its human homologue, hGPBP.
His second notable patent focuses on CYR61 compositions and methods. It details polynucleotides that encode mammalian ECM signaling molecules, showcasing their impact on biological processes such as angiogenesis, chondrogenesis, and oncogenesis. This patent includes comprehensive compositions of DNAs and RNAs associated with ECM signaling and discusses polypeptide forms that contain inhibitory peptides and antibody products that can interact with the Cyr61 protein.
Career Highlights
Cho-Yau Yeung is currently associated with Munin Corporation, where he continues to drive innovation in the life sciences. His work has the potential to influence treatment methods for various diseases, particularly those linked to cell adhesion and migration, thereby making a profound impact on medical and therapeutic strategies.
Collaborations
Throughout his career, Yeung has collaborated with talented professionals, including notable coworkers Li-Chung Hsu and Shu Liu. These collaborations further enrich his research and development endeavors, fostering a creative environment conducive to groundbreaking discoveries in biotechnology.
Conclusion
In conclusion, Cho-Yau Yeung stands out as an inventor whose work at Munin Corporation is shaping the future of molecular biology. His contributions to transcription regulation and ECM signaling demonstrate the significance of innovative research in tackling complex biological challenges. With ongoing advancements likely to emerge from his patents, Yeung's impact on the scientific community is poised to grow even further.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile